Special CME - Sept. 10, 2020
"Psilocybin Therapy for Relief of Refractory Anxiety and Depression in Terminally Ill Patients"

Kathryn Tucker, JD, Special Counsel, Emerge Law Group


  1. Understand Measure 109 and recognize its implications for relief of non physical suffering in patients with terminal illness, PTSD and other difficult conditions.
  2. Identify types of suffering of psychological, emotional, social, spiritual, or existential nature that are potential indications for supervised therapy involving psilocybin.

Accreditation: St. Charles Health System is accredited by the Oregon Medical Association to provide continuing medical education for physicians. St. Charles Health System designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)TM.

Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Claim Credit

Target Audience: Physicians, Nurses, Pharmacists, Allied Health Professionals

Accessibility/Program Questions: St. Charles Health System encourages persons with disabilities to participate in its programs and activities. If you anticipate needing any type of accommodation or have questions about the physical access provided, please contact Lisa Nasr, CME Coordinator at 541-706-4767, For CME or Clerkship questions, contact Sheila Jordan, MMGT, CHCP, Manager of Continuing Medical Education at 541-706-6780,

topics in this article